https://www.selleckchem.com/products/arq531.html
25.9 months, range 3.5-98.7 months, P = 0.0005) compared to other responders. Younger patients ( less then 69 years) had longer median MSS (47.2 months, range 3.5-138.7 vs. 25.9 months, range 8.4-125.4 months, P = 0.015) compared to patients over 69 years. Treatment outcomes of Finnish ILP patients were comparable to earlier studies and some long-term survivors were observed in the group of complete responders. Median PFS and OS were longer for patients achieving a CR. Treatment was well-tolerated also among older patients. Stone, MH, Ho
Like
Comment
Share
